Sbi Securities Co., Ltd. Bio Atla, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Bio Atla, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 825 shares of BCAB stock, worth $420. This represents 0.0% of its overall portfolio holdings.
Number of Shares
825Holding current value
$420% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BCAB
# of Institutions
64Shares Held
17.4MCall Options Held
500Put Options Held
33.5K-
Israel Englander Millennium Management LLC | New York, Ny2.66MShares$1.36 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.52MShares$1.28 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$961,4780.0% of portfolio
-
Morgan Stanley New York, NY1.86MShares$947,6690.0% of portfolio
-
Tang Capital Management LLC San Diego, CA874KShares$445,7780.13% of portfolio
About BioAtla, Inc.
- Ticker BCAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,304,100
- Market Cap $18.5M
- Description
- BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...